Atlas Trials

Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies

Clinical trial NCT00669097 · COMPLETED

Trial details

NCT number
NCT00669097
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Malignancies
Start date
2008-04-01
Primary completion
2010-01-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.